Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.30%
#2 Victoria VR Victoria VR +9.12%
#3 Movement Movement +8.40%
#4 COTI COTI +7.33%
#5 DMT-NAT DMT-NAT +6.93%
#6 Palladium Network Palladium Network +4.63%
#7 Prom Prom +4.55%
#8 Test Test +4.07%
#9 GRVT Token GRVT Token +3.80%
#10 Cryptopia Cryptopia +3.74%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Settings
Language
ENGLISH
Currency
USD
Theme
Hydrogen Hybrid Technologies, Inc. Hydrogen Hybrid Technologies, Inc.

Hydrogen Hybrid Technologies, Inc.

HYHY
Rank in Stocks #42261
Hydrogen Hybrid Technologies, Inc. manufactures, sales and distributes on-board... Hydrogen Hybrid Technologies, Inc. manufactures, sales and distributes on-board hydrogen generating and injections systems for the original equipment manufacturers in car and light truck markets. Its on-board hydrogen generating system improves fuel consumption and reduces pollution through the enhancement of the internal combustion process. This technology consists of an on-board system, which generates hydrogen and oxygen by splitting distilled water. In addition, the company holds rights to distribute the product to other markets, including the heavy goods vehicle market. Hydrogen Hybrid Technologies, Inc. is based in Pickering, Canada.
Share Price
$0.00003
Last synced: 2026-08-11
Market Cap
$2.81K
Change (1 day)
0.00%
Change (1 year)
-85.00%
Country
CA
Trade Hydrogen Hybrid Technologies, Inc. (HYHY)

Category

Healthcare
P/E ratio for Hydrogen Hybrid Technologies, Inc. (HYHY)
P/E ratio as of 2026 TTM: 0
According to Hydrogen Hybrid Technologies, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Hydrogen Hybrid Technologies, Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 23.71 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 220.17 -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.